Global Clinical Trial Materials and Supplies Markets, 2020-2025 - Rising Investments and Government Funding for Clinical Trials, Increasing Number of Patent Expirations
DUBLIN, Feb. 25, 2020 /PRNewswire/ -- The "Clinical Trial Materials and Supplies Market by Service (Logistics, Manufacturing), Clinical Trial Type (Therapeutic, Diagnostics), Phase (Phase 2, Phase 3), Medical Specialty (Oncology, Diabetes), and End User (Pharmaceutical, CRO)- Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Clinical Trial Materials & Supplies Market is expected to reach $25.9 billion by 2025, at a CAGR of 6% during the forecast period of 2019 to 2025.
The factors such as growing advancements in clinical trial material supply chain process; emerging markets in developing regions; rising investments and government funding; and growing number of patent expiration are driving the growth of the global clinical trial materials and supplies market. However, the changing regulatory landscape is expected to hinder the growth of the global clinical trial materials and supplies market.
Based on services, the logistics and distribution segment is estimated to command the largest share of the overall clinical trial materials and supplies market in 2019. The large share of this segment is mainly attributed to the rising R&D cost, increased competition among small and mid-size manufacturers, and stringency over the prices of the medicine. Also, the increasing demand for biological and orphan drugs further promotes the growth of this segment.
Based on end user, the pharmaceutical and biologics segment is estimated to account for the largest share of the overall market in 2019. However, the contract research organizations (CROs) segment is expected to grow at the higher CAGR during the forecast period. The rapid growth of this segment is attributed to the increasing interest of the drug manufacturers to outsource their clinical trials to the CROs.
An in-depth analysis of the geographic scenario of the clinical trial materials and supplies market provides detailed qualitative and quantitative insights about the six major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa) along with the coverage of major countries in each region.
North America commanded the largest share of the overall clinical trial materials and supplies market in 2019, followed by Europe and Asia Pacific. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period. The rapid growth in this region is attributed to the increasing prevalence of various chronic diseases in the region, low cost of conducting a clinical trial as compared to the western region, and increasing government initiatives to conduct clinical trials. Moreover, due to the stringent regulations for importing clinical supplies, end-users are expected to strengthen their domestic presence in these countries.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.2.1. Developing Countries with High Recruitments and the Low Cost of Clinical Trials
4.2.2. Technological Advancements in Clinical Trial Supply Chain Process
4.2.3. Rising Investments and Government Funding for Clinical Trials
4.2.4. Strategic Developments among the Solution Providers
4.2.5. Increasing Number of Patent Expiration
4.3. Restraints
4.3.1. Changing Regulatory Landscape
4.4. Opportunities
4.4.1. High Growth in Developing Countries
4.5. Challenges
4.5.1. Clinical Trials Supply Challenge with IRT
4.6. Trends
4.6.1. Outsourcing of Clinical Trial Supplies
4.7. Market Share Analysis, by Key Players
5. Regulatory Analysis
5.1. Introduction
5.2. Global Regulations
5.2.1. EU Labelling Requirements
5.2.1.1. Food and Drug Administration
5.3. Regional Regulations
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. Middle East and Africa
6. Clinical Trial Materials and Supplies Market, by Services
6.1. Introduction
6.2. Logistics and Distribution
6.3. Manufacturing and Packaging
6.3.1.1. IMPs and INDs
6.3.1.2. Placebos
6.3.1.3. Assays and Test kits
6.3.1.4. Other Materials
6.4. Documentation
6.5. Quantitative Clinical Development
6.6. Clinical Operations
7. Clinical Trial Materials and Supplies Market, by Clinical Trial Type
7.1. Introduction
7.2. Therapeutic and Prevention
7.2.1. Vaccines
7.2.2. Drug Discovery and Development
7.2.3. Therapeutic Devices
7.2.4. Biosimilars
7.2.5. Therapeutic Assay
7.2.6. Therapeutic Procedures
7.3. Diagnostics
7.3.1. Diagnostic Assay
7.3.2. Diagnostic Devices
8. Clinical Trial Materials and Supplies Market, by Phase
8.1. Introduction
8.2. Phase 3
8.3. Phase 2
8.4. Phase 1
9. Clinical Trial Materials and Supplies Market, by Medical Specialty
9.1. Introduction
9.2. Oncology
9.3. CNS And Mental Disorders
9.4. Diabetes
9.5. Cardiovascular Diseases
9.6. Dermatology
9.7. Respiratory Diseases
9.8. Blood Disorder
9.9. Gastrointestinal Diseases
9.10. Infectious Diseases
9.11. Ophthalmology
9.12. Rare Diseases
10. Global Clinical Trial Materials and Supplies Market, by End-Users
10.1. Introduction
10.2. Pharmaceutical and Biologics
10.3. Contract Research Organizations
10.4. Medical Device Companies
11. Clinical Trial Materials and Supplies Market, by Geography
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia and New Zealand
11.4.5. Rest of Asia Pacific
11.5. Latin America
11.6. Middle East and Africa
12. Competitive Landscape
12.1. Introduction
12.2. Alliances and Acquisitions
12.3. New Product Launches
12.4. Partnerships, Agreements, and Collaborations
12.5. Expansions
13. Company Profiles
(Business Overview, Financial Overview, Product & Services Portfolio, Strategic Developments)
13.1. Thermo Fisher Scientific Inc.
13.1.1. Fisher Clinical Services Inc.
13.1.2. Patheon
13.2. Capsugel Inc. (Subsidiary of Lonza Group)
13.3. Parexel International Corporation (Subsidiary of Pamplona Capital Management, LLP)
13.4. Eurofins Scientific Inc.
13.5. Almac Group Ltd.
13.6. Catalent, Inc.
13.7. Intertek Group PLC
13.8. Mayne Pharma Group Ltd.
13.9. Biocair International Ltd.
13.10. Recipharm AB
13.11. Avomeen Analytical Services Inc.
13.12. Bilcare Inc.
For more information about this report visit https://www.researchandmarkets.com/r/clk1cj
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article